• 1
    Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992; 15: 94863.
  • 2
    Okita K. Management of hepatocellular carcinoma in Japan. J. Gastroenterol. 2006; 41: 1006.
  • 3
    Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 190717.
  • 4
    Song TJ, Ip EW, Fong Y. Hepatocellular carcinoma: current surgical management. Gastroenterology 2004; 127: S24860.
  • 5
    Jansen MC, Van Hillegersberg R, Chamuleau RA, Van Delden OM, Gouma DJ, Van Gulik TM. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur. J. Surg. Oncol. 2005; 31: 33147.
  • 6
    Gough-Palmer AL, Gedroyc WM. Laser ablation of hepatocellular carcinoma-A review. World J. Gastroenterol. 2008; 14: 71704.
  • 7
    Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210: 65561.
  • 8
    Orlacchio A, Bazzocchi G, Pastorelli D et al. Percutaneous cryoablation of small hepatocellular carcinoma with US guidance and CT monitoring: initial experience. Cardiovasc. Interv. Radiol. 2008; 31: 58794.
  • 9
    Shiina S, Teratani T, Obi S et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129: 12230.
  • 10
    Yamashiki N, Kato T, Bejarano PA et al. Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: review of 15 explanted livers. Am. J. Gastroenterol. 2003; 98: 20529.
    Direct Link:
  • 11
    Huang GT, Lee PH, Tsang YM et al. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann. Surg. 2005; 242: 3642.
  • 12
    Lencioni R, Llovet JM. Percutaneous ethanol injection for hepatocellular carcinoma: alive or dead? J. Hepatol. 2005; 43: 37780.
  • 13
    Kitamoto M, Imagawa M, Yamada H et al. Radiofrequency ablation in the treatment of small hepatocellular carcinomas: comparison of the radiofrequency effect with and without chemoembolization. AJR Am. J. Roentgenol. 2003; 181: 9971003.
  • 14
    Buscarini L, Buscarini E, Di Stasi M, Vallisa D, Quaretti P, Rocca A. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur. Radiol. 2001; 11: 91421.
  • 15
    Tateishi R, Shiina S, Teratani T et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005; 103: 12019.
  • 16
    Hayashi M, Matsui O, Ueda K, Kawamori Y, Gabata T, Kadoya M. Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. Radiology 2002; 225: 1439.
  • 17
    Lim JH, Choi D, Kim SH et al. Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual-phase helical CT. AJR Am. J. Roentgenol. 2002; 179: 6773.
  • 18
    Spreafico C, Marchiano A, Mazzaferro V et al. Hepatocellular carcinoma in patients who undergo liver transplantation: sensitivity of CT with iodized oil. Radiology 1997; 203: 45760.
  • 19
    Goldberg SN, Grassi CJ, Cardella JF et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005; 235: 72839.
  • 20
    Lencioni R, Cioni D, Crocetti L et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234: 9617.
  • 21
    Machi J, Bueno RS, Wong LL. Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma. World J. Surg. 2005; 29: 136473.
  • 22
    Raut CP, Izzo F, Marra P et al. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann. Surg. Oncol. 2005; 12: 61628.
  • 23
    Choi D, Lim HK, Rhim H et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur. Radiol. 2007; 17: 68492.
  • 24
    Lu DS, Raman SS, Limanond P et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J. Vasc. Interv. Radiol. 2003; 14: 126774.
  • 25
    Chen MH, Yang W, Yan K et al. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation. Clin. Radiol. 2007; 62: 75260.
  • 26
    Fujioka C, Horiguchi J, Ishifuro M et al. A feasibility study: evaluation of radiofrequency ablation therapy to hepatocellular carcinoma using image registration of preoperative and postoperative CT. Acad. Radiol. 2006; 13: 98694.
  • 27
    Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-termresults of treatment and prognostic factors. Ann. Surg. 1999; 229: 21622.
  • 28
    Shimada M, Takenaka K, Gion T et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 1996; 111: 7206.
  • 29
    Jeong S, Aikata H, Katamura Y et al. Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma. World J. Gastroenterol. 2007; 13: 518895.
  • 30
    Jeong SC, Aikata H, Katamura Y et al. Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma. World J. Gastroenterol. 2007; 13: 534350.
  • 31
    Muto Y, Moriwaki H, Ninomiya M et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N. Engl. J. Med. 1996; 334: 15617.